Search clinical trials for: 111I-n panitumumab

Total 2386 results

Philogen S.p.A.
Eudax S.r.l.

Completed

A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer

Cancer

Italy
Hospices Civils de Lyon

Completed

Evaluation of the Effect of a Visio-Hearing Training Protocol on Spatial Hearing in Subjects With Hearing Loss (EVA)

Hearing Loss | Deafness | Cochlear Hearing Loss | Cochlear Nerve Deafness | Cochlear Diseases

France
Bayer

Completed

Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose (LEADER 75)

Magnetic Resonance Imaging

United States, Korea, Republic of, France, Germany, Italy, Switzerland, United Kingdom
Veru Inc.

Completed

VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study (VERU-111)

SARS-CoV Infection

United States, Argentina, Brazil, Bulgaria, Colombia, Mexico
Veru Inc.

Completed

COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111

Respiratory Distress Syndrome, Adult

United States
MetiMedi Pharmaceuticals

Unknown

OMT-111 for Terminal Stage Solid Tumors

Breast Cancer | Pancreatic Cancer | Lung Cancer

Vietnam
Biomedical Radiation Sciences
Swedish Cancer Society

Completed

Exploratory Study of Breast Cancer With ABY025 (ABY0125)

Breast Cancer

Sweden
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Lung Cancer

United States
Gesellschaft fur Medizinische Innovation - Hamatologie...
Amgen

Completed

Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and Thrombocytopenia (EUROPE)

Myelodysplastic Syndromes

France, Germany
Glycom, Inc.
University of North Carolina

Completed

Effect of HMOs as Nutritional Support for Normal Bowel Movements in IBS Patients (GRIPS)

Irritable Bowel Syndrome (IBS)

United States
Beijing Normal University

Unknown

High Working Memory Load to Reduce Internet Gaming Disorder (IGD) Cravings

Internet Gaming Disorder

China
Bionorica SE

Completed

Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)

Urinary Tract Infection

Ukraine
ElectroCore INC

Completed

Non-Invasive Neurostimulation For the Relief of Symptoms Associated With Migraine

Migraine

United States
Institute of Cancer Research, United Kingdom

Terminated

Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer (EVOLUTION)

Metastatic Breast Cancer

United Kingdom
University Health Network, Toronto

Recruiting

Pain Phenotyping in Knee OA: a Pilot Trial

Osteo Arthritis Knee | Chronic Post-operative Pain

Canada
National Jewish Health
Boehringer Ingelheim

Completed

COPDGene/Lung Cancer Center Database

Lung Cancer | COPD

United States
PluroGen Therapeutics, Inc
Arkios BioDevelopment International

Completed

Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers

Diabetic Foot Ulcer | Infection

United States
Herzog Hospital

Withdrawn

Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia

Psychotic Disorders | Schizophrenic Disorders | Schizophrenias | Psychoses

Israel
Massachusetts General Hospital

Terminated

Perioperative Panitumumab and Epirubicin, Oxaliplatin and Xeloda (EOX) in Patients With Gastroesophageal Adenocarcinoma (EOXP)

Gastric Adenocarcinoma | Esophageal Adenocarcinoma

United States
Pontificia Universidad Catolica de Chile
Millennium Institute on Immunology and Immunotherapy; Comisión Nacional de...

Completed

A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV (EVA-VRS01)

Respiratory Syncytial Virus Infections

Chile
Pfizer

Completed

Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors

Metastatic Colorectal Cancer

Belgium, Canada, France, Spain, United States, Italy, Netherlands
Amgen

Terminated

Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint (APPRISE 1)

Pancreatic Cancer | Pancreas Cancer | Cancer of Pancreas | Cancer of the Pancreas
Leiden University Medical Center

Unknown

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

Netherlands
Hellenic Cooperative Oncology Group
Amgen

Terminated

Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer (A-REPEAT)

Advanced Colorectal Cancer

Greece, Cyprus
Guerbet

Completed

Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography

MR Mammography With Dotarem
Guerbet

Completed

Safety and Dialysability of Dotarem® in Dialysed Patients

End-stage Renal Failure

Belgium
Makerere University
Charite University, Berlin, Germany

Not yet recruiting

Airway Microbiome and Th17-mediated Inflammation in COPD Among HIV-infected Individuals in a Rural Ugandan Cohort (HLM)

HIV Infections | COPD | Respiratory Disease

Uganda
Center for Eye Research Australia

Recruiting

Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression (Project AMD)

Age-related Macular Degeneration | Geographic Atrophy | Age Related Macular Degeneration | AMD

Australia
University of Stellenbosch
University of Cape Town

Terminated

Cognitive Training in Obsessive Compulsive Disorder (CTOCD)

Obsessive-Compulsive Disorder

South Africa
Maureen T Greene

Completed

Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Patients

Ambulatory Care | Cancer-related Problem/Condition

United States
University of California, San Francisco
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Transforming Research and Clinical Knowledge in TBI Pilot

Traumatic Brain Injury

United States
University Hospital, Basel, Switzerland

Terminated

n-3 Enriched Nutrition Therapy and Postoperative Cognitive Dysfunction After Cardiac Surgery

Postoperative Cognitive Dysfunction | Delirium, Dementia, Amnestic, Cognitive Disorders

Switzerland
BioMarin Pharmaceutical

Completed

Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI

Mucopolysaccharidosis VI

United States
BioMarin Pharmaceutical

Completed

Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI

Mucopolysaccharidosis VI

United States
WiSP Wissenschaftlicher Service Pharma GmbH
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH

Unknown

Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III) (NEO-RIT)

Rectal Cancer

Germany
Alanya Alaaddin Keykubat University

Completed

Affects of Different Vertebral Manipulation Techniques on Chronic Low Back Pain

Chronic Low-back Pain

Turkey
Small Pharma Ltd

Completed

SPL026 With or Without SSRIs in Participants With MDD

Major Depressive Disorder

United Kingdom
Guerbet

Completed

Renal Safety Evaluation After Dotarem®-Enhanced MRI (RESCUE)

Renal Insufficiency

France, Belgium, Spain, Italy
Hinova Pharmaceuticals Inc.

Recruiting

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC).

mCRPC

China
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

Leishmaniasis, Mucocutaneous

Peru
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

Cutaneous Leishmaniasis

Colombia
N&N Pharmaceuticals Inc.

Unknown

Evaluating the Safety and Plasma Levels of N-Methanocarbathymidine (N-MCT) in Normal Patients

Toxicity

United States
University of Birmingham

Unknown

Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery (FOxTROT)

Colorectal Cancer

United Kingdom
Loma Linda Oncology Medical Group, Inc.

Unknown

Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer

Colorectal Cancer

United States
Arbeitsgemeinschaft medikamentoese Tumortherapie
Amgen

Terminated

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

KRAS Wild Type | Resectable Type II Gastric Adenocarcinoma

Austria
IDRI
Bill and Melinda Gates Foundation

Completed

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

Visceral Leishmaniasis | Post-kala-azar Dermal Leishmaniasis

India
Herbert Hurwitz, MD
Novartis; Genentech, Inc.; Amgen

Completed

BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab) (BEP)

Solid Tumors

United States
National Center for Research Resources (NCRR)

Unknown

CHP677: I-Metaiodobenzylguanidine (I-MIBG) Therapy for Refractory Neuroblastoma: a Phase II Study

Neuroblastoma

United States
Bayer

Recruiting

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) (Quanti OBR)

Contrast Enhancement in Magnetic Resonance Imaging | Non-central Nervous System Pathology

United States, Sweden, Japan, Czechia, China, Hungary, Poland, Italy, United Kingdom, Turkey, Korea, Republic of, Germany, Taiwan, France, Argentina, Bulgaria, Canada
Bayer

Recruiting

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems (Quanti CNS)

Contrast Enhancement in Magnetic Resonance Imaging | Central Nervous System Pathology

France, Turkey, Czechia, China, Japan, Korea, Republic of, United Kingdom, Italy, United States, Hungary, Argentina, Bulgaria, Canada, Germany, Sweden

Search clinical trials for: 111I-n panitumumab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations